Deyun Luo

1.3k total citations
22 papers, 206 citations indexed

About

Deyun Luo is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Deyun Luo has authored 22 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 8 papers in Oncology. Recurrent topics in Deyun Luo's work include Gastric Cancer Management and Outcomes (10 papers), Colorectal Cancer Treatments and Studies (5 papers) and Metastasis and carcinoma case studies (4 papers). Deyun Luo is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Colorectal Cancer Treatments and Studies (5 papers) and Metastasis and carcinoma case studies (4 papers). Deyun Luo collaborates with scholars based in China and United States. Deyun Luo's co-authors include Zhengyin Liao, Meng Qiu, Qiulin Tang, Ming Liu, Yi Zheng, Feng Bi, Feng Xu, Meng Qiu, Jiyan Liu and Yajie Zhu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Cancer.

In The Last Decade

Deyun Luo

20 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deyun Luo China 7 113 76 52 42 38 22 206
David Papadimos Australia 8 62 0.5× 87 1.1× 70 1.3× 40 1.0× 43 1.1× 11 205
Kunli Du China 11 122 1.1× 121 1.6× 46 0.9× 66 1.6× 72 1.9× 25 269
Katsuji Marukawa Japan 7 60 0.5× 99 1.3× 64 1.2× 47 1.1× 43 1.1× 14 216
Leo Yamada Japan 7 78 0.7× 150 2.0× 54 1.0× 56 1.3× 33 0.9× 18 233
Elena Molina Roldán Spain 8 63 0.6× 68 0.9× 67 1.3× 38 0.9× 46 1.2× 16 178
Alessandro Cavaliere Italy 9 90 0.8× 148 1.9× 57 1.1× 57 1.4× 82 2.2× 12 251
Papa Diogop Ndiaye Senegal 8 71 0.6× 49 0.6× 23 0.4× 34 0.8× 31 0.8× 21 170
Zhongxue Su China 10 183 1.6× 124 1.6× 34 0.7× 66 1.6× 132 3.5× 11 321
Masataka Shimonosono Japan 10 124 1.1× 114 1.5× 77 1.5× 67 1.6× 104 2.7× 29 286
Chuanqiang Wu China 7 174 1.5× 97 1.3× 27 0.5× 32 0.8× 104 2.7× 16 268

Countries citing papers authored by Deyun Luo

Since Specialization
Citations

This map shows the geographic impact of Deyun Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deyun Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deyun Luo more than expected).

Fields of papers citing papers by Deyun Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deyun Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deyun Luo. The network helps show where Deyun Luo may publish in the future.

Co-authorship network of co-authors of Deyun Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Deyun Luo. A scholar is included among the top collaborators of Deyun Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deyun Luo. Deyun Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Deyun, et al.. (2025). Association of LDL‐C/HDL‐C Ratio With Hyperuricemia: A National Cohort Study. Clinical and Translational Science. 18(1). e70122–e70122. 1 indexed citations
2.
3.
4.
5.
6.
Shi, Xiaoxiao, Xianguo Liu, Zhe Liu, et al.. (2024). Evaluating Oral Probiotic Supplements as Complementary Treatment in Advanced Lung Cancer Patients Receiving ICIs: A Prospective Real-World Study. Cancer Control. 31. 2925672007–2925672007. 7 indexed citations
7.
8.
Zhu, Yueting, Xin‐Zu Chen, Ye Chen, et al.. (2020). Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer. Frontiers in Oncology. 10. 570268–570268. 3 indexed citations
9.
Chen, Ye, Jing Wu, Ke Cheng, et al.. (2019). S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial. The Oncologist. 24(5). 591–e165. 12 indexed citations
10.
Ma, Qingxin, et al.. (2019). A rare case of hepatic sarcomatoid carcinoma: exceeding expectations in a stage IV primary hepatic sarcomatoid carcinoma patient.. PubMed. 12(1). 378–383. 5 indexed citations
11.
12.
Xu, Cheng, et al.. (2016). Clinical significance of serum CA125 in diffuse malignant mesothelioma. SpringerPlus. 5(1). 368–368. 8 indexed citations
13.
14.
Bi, Feng, Qiu Li, Feng Wen, et al.. (2016). Prospective randomized phase II study of FOLFIRI versus FOLFOX7 in advanced gastric adenocarcinoma: A Chinese Western Cooperative Gastrointestinal Oncology Group study.. Journal of Clinical Oncology. 34(4_suppl). 1–1. 2 indexed citations
15.
16.
Shu, Pei, Yali Shen, Yaqin Zhao, et al.. (2015). A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors. Medical Oncology. 32(11). 247–247. 3 indexed citations
17.
Wang, Xin, Yongsheng Wang, Meng Qiu, et al.. (2010). Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen). Medical Oncology. 28(S1). 274–279. 12 indexed citations
18.
Zhou, Jitao, Yajie Zhu, Guoyun Zhang, et al.. (2010). A distinct role of RhoB in gastric cancer suppression. International Journal of Cancer. 128(5). 1057–1068. 52 indexed citations
19.
Zhang, Siyuan, Qiulin Tang, Feng Xu, et al.. (2009). RhoA Regulates G1-S Progression of Gastric Cancer Cells by Modulation of Multiple INK4 Family Tumor Suppressors. Molecular Cancer Research. 7(4). 570–580. 66 indexed citations
20.
Zhu, Yajie, Feng Xu, Juan Huang, et al.. (2008). [Expression of RhoE in lung and breast cancer and its clinical significance.].. SHILAP Revista de lepidopterología. 11(1). 85–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Papadimos Breakdown of academic impact, for papers by Kunli Du Breakdown of academic impact, for papers by Katsuji Marukawa Breakdown of academic impact, for papers by Leo Yamada Breakdown of academic impact, for papers by Elena Molina Roldán Breakdown of academic impact, for papers by Alessandro Cavaliere Breakdown of academic impact, for papers by Papa Diogop Ndiaye Breakdown of academic impact, for papers by Zhongxue Su Breakdown of academic impact, for papers by Masataka Shimonosono Breakdown of academic impact, for papers by Chuanqiang Wu
Rankless by CCL
2026